Signed in as:
filler@godaddy.com
Semaglutide vs Tirzepatide
Semaglutide
Semaglutide
Semaglutide
- A GLP-1 receptor agonist (Glucagon-Like Peptide-1). It works by increasing insulin secretion, slowing gastric emptying, and reducing appetite.
- Proven effective for both blood sugar control and weight loss. Studies show weight reductions of approximately 10-15% for those on high doses.
- Effective for diabetes and weight loss, focusing on GLP-1 pathways.
Tirzepatide
Semaglutide
Semaglutide
- A dual agonist of GLP-1 and GIP (Glucose-Dependent Insulinotropic Polypeptide). The addition of GIP enhances insulin sensitivity and may provide more significant glucose and weight management benefits.
- Demonstrates superior efficacy compared to semaglutide, with weight loss ranging from 15-20% in clinical trials, depending on the dose.
- More potent for both, leveraging dual hormone pathways for enhanced results.